Clinical Trials Browser

Ferrosoferric Oxide × 90 days × Clear all

NCT07461948 2026-03-10

Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients

Phase 3 Recruiting

Glioblastoma

NCT03270059 2026-02-27

Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System

Phase 2 Recruiting

Brain Neoplasms, Cranial Nerve Diseases, Central Nervous System Neoplasms